We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+3.29%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$811M
Cap. Flow
+$429M
Cap. Flow %
2.05%
Top 10 Hldgs %
15.16%
Holding
2,330
New
84
Increased
1,228
Reduced
936
Closed
75

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$42M
2
VZ icon
Verizon
VZ
+$41.3M
3
NEE icon
NextEra Energy
NEE
+$28.9M
4
CHL
China Mobile Limited
CHL
+$24M
5
AMZN icon
Amazon
AMZN
+$22.3M

Top Sells

Rank Stock Value
1
TWX
Time Warner Inc
TWX
+$48.9M
2
MON
Monsanto Co
MON
+$40.2M
3
PG icon
Procter & Gamble
PG
+$27.1M
4
MMM icon
3M
MMM
+$26.7M
5
IBM icon
IBM
IBM
+$24M

Sector Composition

Rank Sector Weight
1 Technology 17.86%
2 Financials 17.23%
3 Healthcare 12.98%
4 Consumer Discretionary 10.12%
5 Industrials 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSIS icon
1801
OSI Systems
OSIS
$3.62B
$440K ﹤0.01%
5,686
-2,907
-34% -$203K
VRTV
1802
DELISTED
VERITIV CORPORATION
VRTV
$440K ﹤0.01%
11,040
-356
-3% -$12.7K
CLF icon
1803
Cleveland-Cliffs
CLF
$6.64B
$439K ﹤0.01%
52,105
-1,365
-3% -$10.9K
KYNB
1804
Kyntra Bio
KYNB
$27.5M
$438K ﹤0.01%
280
+101
+56% +$132K
TPC
1805
Tutor Perini Cor
TPC
$4.38B
$438K ﹤0.01%
23,715
+10,670
+82% +$219K
MTSC
1806
DELISTED
MTS Systems Corp
MTSC
$438K ﹤0.01%
8,321
+1,311
+19% +$68.9K
HRTX icon
1807
Heron Therapeutics
HRTX
$94.1M
$437K ﹤0.01%
11,261
+1,416
+14% +$45.1K
MNTA
1808
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$437K ﹤0.01%
21,371
+3,102
+17% +$66.6K
AHT
1809
Ashford Hospitality Trust
AHT
$20.9M
$436K ﹤0.01%
54
-9
-14% -$62.8K
STKL
1810
DELISTED
SunOpta
STKL
$436K ﹤0.01%
51,879
-1,119
-2% -$8.46K
UFI icon
1811
UNIFI
UFI
$114M
$435K ﹤0.01%
13,715
-1,694
-11% -$55.8K
HAYN
1812
DELISTED
Haynes International, Inc.
HAYN
$434K ﹤0.01%
11,825
-230
-2% -$9.28K
ABG icon
1813
Asbury Automotive
ABG
$4.34B
$433K ﹤0.01%
6,321
-912
-13% -$63.9K
ASND icon
1814
Ascendis Pharma A/S
ASND
$16.5B
$433K ﹤0.01%
6,502
-3,557
-35% -$234K
MRC
1815
DELISTED
MRC Global
MRC
$433K ﹤0.01%
19,995
-1,702
-8% -$33.6K
SBGI icon
1816
Sinclair Inc
SBGI
$994M
$433K ﹤0.01%
13,465
-195
-1% -$5.84K
INVH icon
1817
Invitation Homes
INVH
$17.6B
$430K ﹤0.01%
18,631
-8,103
-30% -$183K
ARR
1818
Armour Residential REIT
ARR
$2.33B
$429K ﹤0.01%
3,760
+1,006
+37% +$116K
MLI icon
1819
Mueller Industries
MLI
$14.8B
$429K ﹤0.01%
58,100
+10,976
+23% +$79.4K
BERY
1820
DELISTED
Berry Global Group, Inc.
BERY
$428K ﹤0.01%
10,138
+535
+6% +$24.8K
CTT
1821
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$428K ﹤0.01%
33,619
-5,638
-14% -$72.6K
ARRY
1822
DELISTED
Array Biopharma Inc
ARRY
$428K ﹤0.01%
25,526
+2,572
+11% +$40.9K
DHIL
1823
DELISTED
Diamond Hill
DHIL
$426K ﹤0.01%
2,192
+1,135
+107% +$225K
PODD icon
1824
Insulet
PODD
$11.5B
$426K ﹤0.01%
4,976
+660
+15% +$59.2K
RARE icon
1825
Ultragenyx Pharmaceutical
RARE
$2.56B
$426K ﹤0.01%
5,547
+472
+9% +$30.5K

Similar funds

Aperio Group's Q2 2018 Portfolio in Review

As of Q2 2018, Aperio Group held 2,330 positions worth $20.9B, up 4% from $20.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Aperio Group's Q2 2018 filing shows 84 new, 1,228 increased, 936 reduced and 75 closed positions. Its largest new stake was Evergy: 203,701 shares worth $11.4M. The largest sale was Time Warner Inc, an estimated $48.9M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q2 2018 buy was Evergy: 203,701 shares worth $11.4M.
  • Aperio Group added most to Pfizer in Q2 2018, an estimated $42M increase.
  • Aperio Group's biggest Q2 2018 reduction was Procter & Gamble, cutting an estimated $27.1M.
  • Aperio Group fully exited Time Warner Inc in Q2 2018, selling an estimated $48.9M.
  • Aperio Group's ten largest holdings make up 15% of its $20.9B portfolio in Q2 2018.
  • Aperio Group opened 84 new positions and closed 75 in Q2 2018.
  • Aperio Group's portfolio value rose 4% quarter-over-quarter to $20.9B.

Based on Aperio Group's 13F filing for Q2 2018, filed 30 Jul 2018.